We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App





Molbio Exhibits Its Novel POC Molecular Platform and Truenat Range of Tests at MEDICA 2021

By LabMedica International staff writers
Posted on 16 Nov 2021

Molbio Diagnostics (Goa, India) exhibited its novel POC Truelab molecular platform and Truenat range of tests at MEDICA 2021, the leading international trade fair for the medical sector. More...

Molbio presented its fully automatic Truelab real time quantitative micro PCR system with a sample to results time of less than one hour. Among the Truelab systems presented at the event was the fully automatic Truelab Uno Dx real time quantitative micro PCR analyzer with a three wavelength system that performs 10-12 tests in eight hours. Molbio also highlighted the fully automatic Truelab Duo real time quantitative micro PCR analyzer with a two channel-three wavelength system that performs 20-24 tests in eight hours, alongside the fully automatic Truelab Quattro real time quantitative micro PCR analyzer with four channel-three wavelength system that performs 40-48 tests in eight hours. Molbio's Truelab also fits in a suitcase that can be transported easily anywhere and used by anyone. The platform can test over 30 diseases with a sample-to-result time of less than an hour, and the results can be transmitted instantly to any place via the IoT enabled platform.

Additionally, Molbio presented its Truenat range of disease-specific real time micro PCR tests at MEDICA 2021. The micro PCR chips are pre-loaded, ready-to-use and disposable. They are disease-specific and can be run on the Truelab Uno Dx/Duo/Quattro to get quantitative real-time PCR results. Among its wide range of Truenat real time micro PCR tests highlighted at the event was Truenat COVID-19, a chip-based RT PCR test for the semi quantitative detection of SARS CoV-2 RNA in human oropharyngeal and nasopharyngeal swab specimen. Molbio also showcased its WHO-endorsed Truenat MTB test for the quantitative detection and diagnosis of Mycobacterium tuberculosis (MTB) in human pulmonary and EPTB specimens that aids in the diagnosis of infection with MTB.

Related Links:
Molbio Diagnostics 


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
Urine Analyzer
respons® UDS100
CMV CLIA Diagnostic
CLIA CMV IgA Screen Group
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Takotsubo syndrome is a condition characterized by acute transient left ventricular systolic dysfunction and can be difficult to distinguish from acute myocardial infarction at presentation (Image Credit: Adobe Stock)

Biomarker Score Helps Differentiate Takotsubo Syndrome from Myocardial Infarction

Takotsubo syndrome, often called broken-heart syndrome, mimics myocardial infarction and can be difficult to triage in emergency settings. It accounts for about 2% of suspected heart attacks and up to... Read more

Molecular Diagnostics

view channel
Image: A research team led by Prof. Hsing I-Ming (center), Professor of the Department of Chemical and Biological Engineering at HKUST, has developed TEMPO, a thermodynamically programmed one-pot CRISPR platform for rapid, point-of-care nucleic acid testing. Mr. Wu Xiaolong (third right) and Ms. Li Yanan (first left), PhD students from the Department of Chemical and Biological Engineering, are the co-first authors of this study. (Photo courtesy of HKUST)

Single-Tube CRISPR Test Detects Pathogens and Genetic Variants in 30 Minutes

Rapid, accurate detection of infectious agents and single-nucleotide variants remains difficult to deliver outside centralized laboratories. Although multi-step nucleic acid workflows are sensitive, they... Read more

Microbiology

view channel
Image Credit: Adobe Stock

Gut Microbiome Classifier Improves Colorectal Cancer Risk Stratification

Colorectal cancer remains a leading cause of cancer mortality, and current noninvasive screening methods still miss many precancerous lesions. Clinicians therefore need tools that improve risk stratification... Read more

Pathology

view channel
Image Credit: Adobe Stock

New Journal Addresses Evolving Needs in Clinical and Translational Pathology

Clinical pathology underpins diagnosis and therapy selection across oncology and other major diseases, but the field is rapidly evolving as new technologies reshape how disease is studied and classified.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.